The Nation - News from Dec. 11, 1987
Armour Pharmaceutical is recalling 208 lots of a blood clotting agent distributed for hemophilia patients because of the possibility it could contain the AIDS virus, the Food and Drug Administration said. The FDA announcement said the Bluebell, Pa., firm estimates that 2,000 to 5,000 doses of the clotting agent called H. T. Factorate are on the market in the United States. Six patients in Canada who were taking doses from lots processed using the same heat treatment have tested positive for the AIDS virus.
Start your day right
Sign up for Essential California for news, features and recommendations from the L.A. Times and beyond in your inbox six days a week.
You may occasionally receive promotional content from the Los Angeles Times.
